Analyst Ratings for Tandem Diabetes Care (TNDM)
TNDM Rating Summary
TNDM Price Target Summary
- Highest: $55.00 (Barclays)
- Lowest: $14.00 (Nephron)
- Average: $28.35
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$28.35 (+74.7%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
Avg. $ Target:
$28.35 (+74.7%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/1/2026 | Wells Fargo | Lawrence Biegelsen | Upgrade | Overweight (Equal Weight) |
27.00 (21.00) |
16.72 (16.23) |
-2.93% | Details |
| 5/11/2026 | Benchmark | Bruce Jackson | New Coverage | Hold (N/A) |
N/A (N/A) |
15.48 (16.23) |
4.84% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
